These findings support the notion that endometrial adenocarcinomas are enriched for a unique spectrum of somatic CCND1 alterations, in which a significant number of CCND1 mutations occur in the c-terminal domain of cyclin D1 compared to other cancer subtypes. Here, CCND1 is linked to cancer.